Impact of ELISA and immunoblot as diagnostic tools one year after eradication of Helicobacter pylori in a multicentre treatment study

FEMS Immunology and Medical Microbiology

Volumn 24, Issue 2, 1999, Pages 239-242

  Kist, Manfred ^a   Strobel, Sonja ^a   Kirchner, Thomas ^b   Dammann, Hans Gerd ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c Institute for Clinical Research   (Germany)

Author keywords

Enzyme linked immunosorbert assay; Helicobacter pylori; Immunoblot; Post eradication test; Serology

Indexed keywords

ANTIINFECTIVE AGENT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM ULCER; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0032895523     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00033-4     Document Type: Article

References (15)

1. Atherton J.C. Non-endoscopic tests in the diagnosis of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 11:(Suppl. 1):1997;11-20.
2. Vaira D., Stanghellini V., Menegatti M., et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? Endoscopy. 29:1997;595-601.
3. Megraud F. Diagnosis and candidates for treatment of Helicobacter pylori infection: How should Helicobacter pylori infection be diagnosed? Gastroenterology. 113:1997;93-98.
4. Breslin N.P., O'Morain C.A. Noninvasive diagnosis of Helicobacter pylori infection: a review. Helicobacter. 2:1997;111-117.
5. Glupczynski Y., Burette A., Goosens H., De Prez C., Butzler J.P. Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection. Eur. J. Clin. Microbiol. Infect. Dis. 11:1992;583-588.
6. Perez-Perez G.I., Cutler A.F., Blaser M.J. Value of serology as a noninvasive method for evaluating the efficacy of treatment of Helicobacter pylori infection. Clin. Infect. Dis. 25:1997;1038-1043.
7. Hirschl A.M., Brandstätter G., Dragosics B., et al. Kinetics specific IgG antibodies for monitoring the effect of anti Helicobacter pylori cemotherapy. J. Infect. Dis. 168:1993;763-766.
8. Kosunen T.U., Seppälä K., Sarna S., Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet. 339:1992;893-895.
9. Prasad V.M., Santogade P., Cutler A.F. Helicobacter pylori IgG serology following successful eradication - 4 years follow-up. Gastroenterology. 108:1995;A195.
10. Veenendaal R.A., Pena A.S., Meijer J.L., et al. Long term serological surveillance after treatment of Helicobacter pylori infection. Gut. 32:1991;1291-1294.
11. Wang W.M., Chen C.Y., Jan C.M., et al. Long term follow-up and serological study after therapy of Helicobacter pylori associated duodenal ulcer. Am. J. Gastroenterol. 89:1994;1793-1796.
12. Oderda G., Vaira D., Ainley G., et al. Eighteen month follow up of Helicobacter pylori positive children treated with amoxycillin and tinidazole. Gut. 33:1992;1328-1330.
13. Fallone C.A., Wild G.E., Goresky C.A., Barkun A.N. Evaluation of IgA and IgG serology for the detection of Helicobacter pylori infection. Can. J. Gastroenterol. 9:1995;105-111.
14. Dammann H.G., Fölsch U.R., Hahn E.G., von Kleist D.H., Klör H.U., Kirchner T., Kist M. Seven vs 14 day treatment with pantoprazole, clarithromycin and metronidazole for cure of H. pylori infection in duodenal ulcer patients. Gut. 41:(Suppl. 1):1997;95.
15. Bereswill S., Fassbinder F., Völzing C., Covacci A., Haas R., Kist M. Hemolytic properties and riboflavin synthesis of Helicobacter pylori: cloning and functional characterization of the ribA gene encoding GTP-cyclohydrolase II that confers hemolytic activity to Escherichia coli. Med. Microbiol. Immunol. 186:1997;177-187.